[Prophylaxis and treatment for invasive fungal infections in solid organ transplant recipients].
Solid organ transplantation is becoming increasingly common in Japan. Despite invasive fungal infections being less common than bacterial and viral infections, fungal infections still result in a higher mortality rate. Empiric and pre-emptive therapy plays an important role in management of invasive fungal infections, because successful treatment is difficult after a definite diagnosis of an invasive disease, especially invasive aspergillosis. Given this situation, to improve outcome, high risk patients need to be identified and antifungal prophylaxis is mandatory in preventing the development of the disease. However, antifungal prophylaxis for solid organ transplant recipients remains controversial. New antifungal agents might change the choice of fungal prevention and treatment.
Mitsutake
Kotaro
K
Infection Control Unit, Department of Clinical Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
D006801:Humans; D009181:Mycoses / Q000188:drug therapy / Q000517:prevention & control*; D016377:Organ Transplantation